HomeIXC • ASX
add
Invex Therapeutics Ltd
Previous close
$0.13
Day range
$0.13 - $0.13
Year range
$0.059 - $0.18
Market cap
9.03M AUD
Avg Volume
41.51K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 421.51K | 78.54% |
Net income | -357.79K | -100.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.60M | -20.86% |
Total assets | 4.72M | -19.46% |
Total liabilities | 176.49K | -63.22% |
Total equity | 4.55M | — |
Shares outstanding | 75.15M | — |
Price to book | 2.08 | — |
Return on assets | -22.31% | — |
Return on capital | -23.18% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -357.79K | -100.71% |
Cash from operations | -389.86K | -222.72% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -389.86K | -256.68% |
Free cash flow | -263.44K | -88.97% |
About
Founded
2019
Website
